77 Prevalence of secondary immunotherapeutic targets in the absence of established immune biomarkers in solid tumors

• Sean Glenn,
• Blake Burgher,
• Sarabjot Pabla,
• Vincent Giamo,
• RJ Seager,
• Erik Van Roey,
• Shuang Gao,
• Mary Nesline,
• Paul DePietro,
• Shengle Zhang,
• Jeffrey Conroy,
• Yong Hee Lee,
• Roger Klein

Affiliations

Sean Glenn

Aff303 OmniSeq, LLC Buffalo NY USA

Blake Burgher

Aff303 OmniSeq, LLC Buffalo NY USA

Sarabjot Pabla

1OmniSeq, Buffalo, NY, USA

Vincent Giamo

Aff4 OmniSeq Inc. 14203 Buffalo NY USA

RJ Seager

OmnSeq, Buffalo, NY, USA

Erik Van Roey

OmnSeq, Buffalo, NY, USA

Shuang Gao

OmnSeq, Buffalo, NY, USA

Mary Nesline

1OmniSeq, Buffalo, NY, USA

Paul DePietro

1OmniSeq, Buffalo, NY, USA

Shengle Zhang

OmnSeq, Buffalo, NY, USA

Jeffrey Conroy

1OmniSeq, Buffalo, NY, USA

Yong Hee Lee

1OmniSeq, Buffalo, NY, USA

Roger Klein

1OmniSeq, Inc., Buffalo, NY, USA